LEXX Lexaria Bioscience Corp.

Fundamentals / CIK 0001348362 / USD

Lexaria Bioscience Corp. reported $194K in revenue and a net loss of $7.73M for the trailing twelve months ended May 31, 2026 (down 100.0% year over year), with a 100.0% gross margin and a -3973.2% operating margin.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open LEXX in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

10 fiscal years (2016 to 2025), reported in USD.

$7.76M$3.88M$0-$11.69MFY 2016 Revenue: $41KFY 2016 Net Income: -$1.28M2016FY 2017 Revenue: $64KFY 2017 Net Income: -$1.93M2017FY 2018 Revenue: $433KFY 2018 Net Income: $6.60M2018FY 2019 Revenue: $223KFY 2019 Net Income: $4.10M2019FY 2020 Revenue: $315KFY 2020 Net Income: -$4.08M2020FY 2021 Revenue: $723KFY 2021 Net Income: -$4.03M2021FY 2022 Revenue: $255KFY 2022 Net Income: -$7.27M2022FY 2023 Revenue: $86KFY 2023 Net Income: -$6.66M2023FY 2024 Revenue: $464KFY 2024 Net Income: -$5.80M2024FY 2025 Revenue: $706KFY 2025 Net Income: -$11.90M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Aug 31 Aug 31 Aug 31 Aug 31 Aug 31 Aug 31 Aug 31 Aug 31 Aug 31 Aug 31
Revenue $706K $464K $86K $255K $723K $315K $223K $433K $64K $41K
Cost of Revenue $2.7K $4.8K $32K $72K $175K $99K $23K $25K $30K $46K
Gross Profit $703K $459K $195K $184K $547K $215K $200K $408K $34K -$4.9K
Research & Development $8.24M $2.36M $3.67M $1.84M $1.26M $387K $556K $493K $54K $9.0K
Total Operating Expenses $12.58M $6.21M $6.73M $6.80M $6.23M $4.36M $4.36M $7.02M $1.96M $1.27M
Operating Income -$11.88M -$5.75M -$6.53M -$6.62M -$5.69M -$4.15M -$4.16M -$6.61M -$1.93M -$1.28M
EBITDA -$11.83M -$5.71M -$6.39M -$6.52M -$5.58M -$4.03M -$4.09M -$6.61M -$1.93M -$1.28M
Interest Income $3.0K $14K $43K $29K -- -- -- -- -- --
Interest Expense -- $7.8K $0 -- -- -- -- -- $6.0K $2.2K
Income Before Tax -$11.91M -$5.81M -$6.71M -$7.38M -$4.17M -$3.99M -$4.16M -$6.61M -$1.93M -$1.27M
Income Tax Expense -- -- -- $0 $6.1K $2.3K $18K $0 $0 $0
Net Income -$11.90M -$5.80M -$6.66M -$7.27M -$4.03M -$4.08M $4.10M $6.60M -$1.93M -$1.28M
Basic EPS -- -- -- -- -$0.95 -$1.47 -$0.05 -$0.09 -$0.03 -$0.03
Diluted EPS -$0.66 -$0.47 -$1.01 -- -$0.95 -$1.47 -$0.05 -$0.09 -$0.03 -$0.03
Basic Shares Outstanding -- -- -- -- 4.4M 2.8M 77.8M 71.0M 58.8M 43.8M
Diluted Shares Outstanding 18.0M 12.4M 6.6M -- 4.4M 2.8M 77.8M 71.0M 58.8M 43.8M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-05-31 2026-02-28 2025-11-30 2025-08-31 2025-05-31 2025-02-28 2024-11-30 2024-08-31
Revenue $0 $20K $0 $174K $174K $174K $184K $84K
Cost of Revenue $0 $0 $0 $0 $0 $0 $2.7K $0
Gross Profit $0 $20K $0 $174K $174K $174K $181K $84K
Research & Development $971K $475K $671K $1.88M $2.72M $1.69M $1.95M $967K
Total Operating Expenses $1.99M $1.47M $1.57M $2.86M $3.92M $2.93M $2.87M $2.29M
Operating Income -$1.99M -$1.45M -$1.57M -$2.69M -$3.75M -$2.75M -$2.69M -$2.20M
EBITDA -$1.98M -$1.44M -$1.56M -$2.68M -$3.73M -$2.74M -$2.68M -$2.19M
Interest Income $837 $1.8K $12 $2.8K $190 $0 $11 $7.0K
Income Before Tax -$1.99M -- -- -- -$3.79M -- -- --
Income Tax Expense $14 $2.6K $1.8K -- $0 $0 $0 --
Net Income -$1.99M -$1.45M -$1.60M -$2.70M -$3.79M -$2.71M -$2.70M -$2.18M
Diluted EPS -$0.08 -$0.06 -$0.07 -- -$0.21 -$0.15 -$0.16 --
Diluted Shares Outstanding 24.8M 24.4M 21.4M -- 18.3M 17.5M 16.7M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Aug 31 Aug 31 Aug 31 Aug 31 Aug 31 Aug 31 Aug 31 Aug 31 Aug 31 Aug 31
Cash & Cash Equivalents -- -- -- $5.81M $10.92M $1.29M $1.29M $1.73M $2.53M $93K
Short-Term Investments $143K $56K $126K $347K $834K $19K $64K $10K $0 --
Cash & Short-Term Investments -- -- -- $6.16M $11.75M $1.31M $1.35M $1.74M $2.53M $93K
Accounts Receivable, Net $368K $154K $127K $202K $342K $314K $273K $266K $45K $131K
Inventory -- -- $0 $38K $30K $117K $127K $87K $67K $135K
Total Current Assets $3.47M $7.90M $2.15M $6.98M $12.44M $1.93M $1.82M $2.28M $2.80M $510K
Property, Plant & Equipment, Net $228K $255K $254K $316K $368K $483K $591K $1.2K $1.9K $2.5K
Intangible Assets $308K $517K $463K -- -- $292K $265K $147K $63K $54K
Long-Term Investments $349K $14K $14K -- -- -- -- -- -- --
Total Non-Current Assets $707K $970K $933K $856K $824K $902K $856K $148K $65K $56K
Total Assets $4.18M $8.87M $3.08M $7.83M $13.27M $2.83M $2.68M $2.43M $2.86M $567K
Accounts Payable -- -- -- -- -- -- -- $36K -- --
Deferred Revenue (Current) $0 $5.0K -- $0 -- -- $0 $0 $17K $12K
Total Current Liabilities $1.49M $1.10M $268K $194K $153K $226K $185K $44K $92K $434K
Total Non-Current Liabilities $79K $109K $136K $7.4K $50K $120K $0 $0 $0 $45K
Total Liabilities $1.57M $1.21M $404K $201K $203K $346K $185K $44K $92K $479K
Total Debt (incl. Leases) $109K $275K $328K $50K $129K $36K -- -- -- --
Common Stock $20K $16K $8.1K $6.0K $5.7K $3.0K $79K $76K $68K $51K
Retained Earnings -$63.46M -$51.56M -$45.76M -$39.10M -$31.83M -$27.80M -$23.87M -$19.77M -$13.17M -$11.30M
Accumulated Other Comp. Income -$70K -$20K $0 -- -- -- -- -$14K $0 --
Total Stockholders' Equity $2.99M $8.04M $3.04M $7.95M $13.06M $2.48M $2.49M $2.39M $2.77M $266K
Total Equity $2.60M $7.66M $2.68M $7.63M $13.06M $2.48M $2.49M $2.39M $2.77M $88K

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-05-31 2026-02-28 2025-11-30 2025-08-31 2025-05-31 2025-02-28 2024-11-30 2024-08-31
Cash & Cash Equivalents $3.50M $5.10M $4.30M -- $4.60M $6.50M -- --
Short-Term Investments $142K $141K $143K $143K $34K $74K $40K $56K
Cash & Short-Term Investments $3.64M $5.24M $4.44M -- $4.63M $6.57M -- --
Accounts Receivable, Net $49K $42K $88K $368K $358K $331K $263K $154K
Total Current Assets $4.06M $5.77M $5.36M $3.47M $5.81M $7.72M $8.83M $7.90M
Property, Plant & Equipment, Net $229K $243K $216K $228K $240K $262K $271K $255K
Intangible Assets $339K $318K $308K $308K $516K $506K $505K $517K
Long-Term Investments -- -- -- $349K -- -- -- $14K
Total Non-Current Assets $716K $717K $688K $707K $935K $953K $968K $970K
Total Assets $4.78M $6.49M $6.05M $4.18M $6.74M $8.68M $9.79M $8.87M
Deferred Revenue (Current) -- -- -- $0 $0 $0 $0 $5.0K
Other Current Liabilities $400K $200K $1.50M -- -- -- -- --
Total Current Liabilities $383K $215K $1.46M $1.49M $1.49M $1.82M $298K $1.10M
Total Non-Current Liabilities $54K $62K $71K $79K $87K $94K $102K $109K
Total Liabilities $437K $277K $1.53M $1.57M $1.57M $1.92M $400K $1.21M
Total Debt (incl. Leases) $87K $94K $102K $109K $117K $124K $131K $275K
Common Stock $25K $25K $22K $20K $20K $18K $17K $16K
Retained Earnings -$68.50M -$66.51M -$65.06M -$63.46M -$60.76M -$56.98M -$54.26M -$51.56M
Accumulated Other Comp. Income -$46K -$55K -$76K -$70K -$81K -$118K -$23K -$20K
Total Stockholders' Equity $4.74M $6.60M $4.91M $2.99M $5.55M $7.14M $9.77M $8.04M
Total Equity $4.34M $6.21M $4.52M $2.60M $5.17M $6.76M $9.39M $7.66M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Aug 31 Aug 31 Aug 31 Aug 31 Aug 31 Aug 31 Aug 31 Aug 31 Aug 31 Aug 31
Net Income -$11.91M -$5.81M -$6.71M -$7.38M $4.19M -$4.08M $4.10M $6.60M -$1.93M -$1.28M
Depreciation & Amortization $51K $42K $145K $103K $112K $120K $65K $4.0K $2.4K $619
Stock-Based Compensation $859K $492K $170K $753K $410K $1.14M $627K $2.60M $113K $122K
Change in Receivables -$214K -$36K $27K $137K $190K $91K -$139K -$245K -$7.7K -$6.2K
Change in Inventory -- $0 $43K $2.0K $95K -$4.2K -$47K -$33K -$1.1K -$11K
Operating Cash Flow -$10.45M -$4.96M -$5.88M -$4.88M -$3.99M -$2.62M -$3.01M -$2.52M -$1.55M -$661K
Capital Expenditure -$25K -$43K -$34K -$49K -- $0 -$646K -- $0 -$3.1K
Free Cash Flow -$10.48M -$5.00M -$5.91M -$4.93M -- -$2.62M -$3.65M -- -$1.55M -$664K
Purchases of Investments -- -- -- -- -- -- -- -$70K -- --
Investing Cash Flow -$243K -$189K -$170K -$181K $194K -$27K -$769K -$155K -$9.7K -$20K
Common Stock Issued $6.05M $4.21M $1.59M $0 $9.47M $2.67M $2.33M $1.87M $4.05M $419K
Financing Cash Flow $6.05M $10.32M $1.59M -$45K $13.42M $2.65M $3.33M $1.87M $4.00M $514K
Net Change in Cash -$4.70M $5.15M -$4.46M -$5.10M $9.62M $8.6K -$442K -$806K $2.44M -$167K

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-05-31 2026-02-28 2025-11-30 2025-08-31 2025-05-31 2025-02-28 2024-11-30 2024-08-31
Net Income -$1.99M -$1.45M -$1.60M -$2.70M -$3.79M -$2.72M -$2.71M -$2.19M
Depreciation & Amortization $14K $14K $12K $12K $22K $8.7K $8.7K $16K
Stock-Based Compensation $93K $75K $75K $123K $470K $167K $99K $97K
Change in Receivables -$7.0K $46K $280K -$10K -$27K -$68K -$109K $46K
Change in Inventory -- -- -- -- -- -- -- $0
Operating Cash Flow -$1.64M -$2.16M -$984K -$2.64M -$3.58M -$1.50M -$2.73M -$1.89M
Capital Expenditure $0 -$41K $0 -$1 $1 -$1 -$25K -$43K
Free Cash Flow -$1.64M -$2.20M -$984K -$2.64M -$3.58M -$1.50M -$2.75M -$1.93M
Investing Cash Flow -$27K -$54K -$5.1K -$158K -$19K -$28K -$38K -$70K
Common Stock Issued $0 $3.04M $3.47M $0 $1.69M $12K $4.35M $0
Financing Cash Flow $0 $3.04M $3.47M $0 $1.69M $12K $4.35M $0
Net Change in Cash -$1.65M $847K $2.48M -$2.79M -$1.88M -$1.61M $1.58M -$1.96M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Aug 31 Aug 31 Aug 31 Aug 31 Aug 31 Aug 31 Aug 31 Aug 31 Aug 31 Aug 31
Gross Margin 99.6% 99.0% 225.4% 71.9% 75.7% 68.4% 89.7% 94.2% 53.3% -12.0%
Operating Margin -1683.0% -1239.2% -7564.3% -2591.7% -786.8% -1317.9% -1868.0% -1525.4% -3031.9% -3136.8%
Net Profit Margin -1686.0% -1248.2% -7715.8% -2846.3% -557.2% -1297.6% 1841.8% 1523.2% -3031.9% -3136.8%
Return on Equity (ROE) -398.1% -72.1% -218.9% -91.5% -30.8% -164.6% 164.6% 276.4% -69.7% -480.1%
Return on Assets (ROA) -285.1% -65.4% -216.1% -92.8% -30.4% -144.4% 153.3% 271.4% -67.5% -225.4%
Current Ratio 2.32x 7.18x 8.03x 35.96x 81.18x 8.53x 9.86x 52.34x 30.27x 1.18x
Quick Ratio -- -- 8.03x 35.76x 80.99x 8.01x 9.17x 50.34x 29.54x 0.87x
Debt to Equity 0.04x 0.03x 0.11x 0.01x 0.01x 0.01x -- -- -- --
Revenue Growth (YoY) +52.0% +437.5% -66.2% -64.7% +129.6% +41.4% -48.6% +580.9% +56.3% +177.0%
Gross Profit Growth (YoY) +53.1% +136.0% +6.1% -66.5% +154.1% +7.9% -51.1% +1104.2% -- --
Net Income Growth (YoY) -- -- -- -- -- -199.6% -37.9% -- -- --
5Y Revenue / Share Growth -- -- -- -- +17619.9% +33615.7% -- -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-05-31 2026-02-28 2025-11-30 2025-08-31 2025-05-31 2025-02-28 2024-11-30 2024-08-31
Gross Margin 100.0% 100.0% 100.0% 99.6% 99.6% 99.5% 99.5% 99.0%
Operating Margin -3973.2% -2571.9% -2062.0% -1683.0% -1850.1% -1785.0% -1470.0% -1239.2%
Net Profit Margin -3985.6% -2589.7% -2067.7% -1686.0% -1849.4% -1784.2% -1473.0% -1248.2%
Return on Equity (ROE) -163.2% -144.3% -219.7% -398.1% -205.2% -131.3% -74.9% -72.1%
Return on Assets (ROA) -161.7% -146.9% -178.4% -285.1% -169.0% -108.1% -74.7% -65.4%
Current Ratio 10.60x 26.88x 3.68x 2.32x 3.90x 4.24x 29.64x 7.18x
Quick Ratio 9.63x 24.61x 3.11x -- 3.35x 3.79x -- --
Debt to Equity 0.02x 0.01x 0.02x 0.04x 0.02x 0.02x 0.01x 0.03x
Revenue Growth (YoY) -100.0% -88.5% -100.0% +107.1% +107.1% +20.0% +21.6% +173.3%
Gross Profit Growth (YoY) -100.0% -88.5% -100.0% +107.1% +107.1% +20.0% +23.7% +173.3%
Source: SEC EDGAR CompanyFacts (CIK 0001348362) · from July 31, 2010 Data through May 31, 2026 · synced Nov 21, 2026, 05:07 UTC · Open in terminal